STAGWELL (STGW) Stock News

Kettle, a digital-first creative agency under Stagwell (NASDAQ: STGW), has been named to Adweek's 2025 Fastest Growing Agencies list. The agency demonstrated remarkable growth with a 41% increase in net revenue in 2024 and doubled its size over the past two years while maintaining under 3% employee turnover.

The agency has expanded its client roster to include Warby Parker, Robinhood, e.l.f. Beauty, Legal Aid Society, and Mailchimp, while maintaining strong relationships with existing clients like Apple and T-Mobile. Kettle has established an all-women C-suite led by CEO Lauren Kushner, Chief Creative Officer Camille Imbert, and Chief Product Officer Jess Mireau. The agency was also recognized as one of Ad Age's Best Places to Work 2025.

Stagwell (NASDAQ: STGW) has appointed Meredith Aronson as Vice President of Corporate Affairs to strengthen its Corporate Affairs practice. Aronson brings over 14 years of experience across corporate, nonprofit, and government sectors, including senior leadership roles at JPMorganChase and service in the Obama administration.

In her new role, Aronson will focus on developing integrated communications and reputation strategies while contributing to the network's thought leadership. Her appointment aims to enhance Stagwell's capabilities in reputation management, integrated marketing, communications, research, and stakeholder engagement.

Stagwell (NASDAQ: STGW) and Żabka Polska have formed a joint venture to launch In-Pulse, an advanced consumer analytics and engagement tool specifically designed for the Polish market. The partnership combines Żabka's extensive retail network of over 11,600 stores and 10 million Żappka app users with Stagwell's data-driven marketing expertise.

In-Pulse operates through a five-step process: data collection and analysis, customer dialogue, product/service testing, targeted marketing development, and effectiveness evaluation. The tool processes approximately 4.1 million daily transactions and provides real-time, actionable insights into Polish consumer behavior, helping businesses optimize their marketing strategies and product offerings.

Stagwell (NASDAQ: STGW) has appointed Slavi Samardzija as Chief Data and Platforms Officer in a newly created position, effective September 4, 2025. Samardzija brings over 25 years of experience in data and technology, including 15 years at WPP and 10 years at Omnicom, where he most recently served as Global CEO of Annalect.

In his new role, Samardzija will lead the development of Stagwell's data and platform strategy, focusing on implementing the company's ID Graph and AI-powered orchestration system, The Machine. His extensive background includes building platform and service companies that help Fortune 500 businesses leverage data for B2C and B2B marketing improvements.

Stagwell (NASDAQ: STGW) CEO Mark Penn will headline a Fireside Chat at the Harvard Alumni Entrepreneurs (HAE) Startup World Cup Regional on September 12, 2025 at Harvard Medical School. The event will feature 12 Harvard alumni-founded startups competing for advancement to the Silicon Valley Grand Finale, where they can win a $1 million investment prize from Pegasus Tech Ventures.

Penn, author of Microtrends and Harvard alumnus, will share insights on unicorn trends and market shifts in a conversation moderated by Bill Reichert, Partner at Pegasus Tech Ventures. The event will be held at The Martin Conference Center with both in-person and livestream options available.

Stagwell (NASDAQ: STGW), the challenger marketing network, has announced its participation in three major investor conferences in September 2025. The company will attend the Citi 2025 Global TMT Conference (Sept 3) and Benchmark 12th Annual TMT Conference (Sept 4) for one-on-one meetings. Additionally, CEO Mark Penn will participate in a fireside chat at the Goldman Sachs Communacopia + Technology Conference on September 10 at 4:25 PM PT, along with hosting one-on-one meetings.

Stagwell (NASDAQ: STGW) released the August Harvard CAPS / Harris poll results showing President Trump's approval rating at 47%. The poll reveals that 54% of voters believe Trump is performing better than Biden, up 3 points from July. Key findings include 48% of voters citing inflation as their top personal concern, and Trump maintaining highest approval ratings in fighting crime (51%), immigration (50%), and returning America to its values (50%).

The comprehensive survey, conducted among 2,025 registered voters, also showed strong support for Trump's policies, with 14 out of 15 policies receiving majority approval. Notable findings include 66% of voters demanding more transparency on the Epstein case, 52% satisfaction with Trump's Ukraine war negotiations, and 74% support for Israel in the ongoing conflict with Hamas.

Allison Worldwide and Stagwell (NASDAQ:STGW) have appointed Margaret Key as CEO of Allison Asia and Stagwell's Executive Director for Asia Pacific, effective October 1, 2025. Key, who will be based in Singapore and report to Allison Worldwide CEO Jonathan Heit, brings over 20 years of strategic expertise to this dual role.

Previously serving as CEO for Publicis' MSL Group in Asia Pacific, Key has a proven track record of transforming regional operations and driving business growth. Her industry recognition includes Campaign Asia's Women to Watch and multiple regional awards. In her new role, she will oversee Allison's APAC growth strategy while steering Stagwell's regional market development and client engagement initiatives.

A comprehensive survey conducted by The Harris Poll, a Stagwell (STGW) agency, in partnership with the American Gastroenterological Association (AGA), reveals significant ongoing challenges faced by IBS patients. The study, comparing data from 2015 to 2024, surveyed 2,013 IBS patients and 600 healthcare providers.

Key findings show that IBS symptoms disrupt patients' productivity and personal activities for 19 days monthly, with work/school absences increasing to 3.6 days per month in 2024 from 2.1 days in 2015. While fewer patients report extremely bothersome symptoms (43% vs 62% in 2015), 76% still struggle with symptom management.

The survey highlights a treatment gap, with healthcare providers primarily recommending over-the-counter options and lifestyle changes despite prescription medications being reported as most helpful by patients who have tried them.